biotin has been researched along with n-succinimidyl-3-(4-hydroxyphenyl)propionate in 1 studies
Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (n-succinimidyl-3-(4-hydroxyphenyl)propionate) | Trials (n-succinimidyl-3-(4-hydroxyphenyl)propionate) | Recent Studies (post-2010) (n-succinimidyl-3-(4-hydroxyphenyl)propionate) |
---|---|---|---|---|---|
14,847 | 95 | 3,882 | 133 | 0 | 13 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldstein, A; Naidu, A; Nestor, JJ; Newman, SR | 1 |
1 other study(ies) available for biotin and n-succinimidyl-3-(4-hydroxyphenyl)propionate
Article | Year |
---|---|
"DAKLI": a multipurpose ligand with high affinity and selectivity for dynorphin (kappa opioid) binding sites.
Topics: Animals; Avidin; Binding Sites; Biotin; Brain; Dynorphins; Fluorescein-5-isothiocyanate; Fluoresceins; Guinea Pigs; Peptides; Receptors, Opioid; Receptors, Opioid, kappa; Succinimides; Thiocyanates | 1988 |